Image
21.04.2023
Forest Gate runner takes on London Marathon challenge for Diabetes UK
A Diabetes UK employee from Forest Gate, Newham is taking on the challenge of a lifetime to run this year...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more